TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BOEHRINGER INGELHEIM · pharmaceutical company focused on innovative therapies for diseases w/o treatment option

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $70,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Budget/Appropriations

federal budget issues

Medicare/Medicaid

Lobbying related to Medicare & Medicaid coverage and payment issues

Health Issues

Lobbying related to pharmaceutical policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.